Skip to main content
. 2022 Jul 28;12:12962. doi: 10.1038/s41598-022-17241-9

Figure 1.

Figure 1

Pre-existing immunity against SARS-CoV-2 S and N protein in various populations. Serological screening for the presence of IgG against SARS-CoV-2 S (A,D) and N protein (B,D). Sera from Quebec (n = 41), Denmark (n = 117), Brazil (n = 108) and Gabon (n = 116), and 11 COVID-19 confirmed cases (A,B) as well as pre-pandemic (n = 128), and COVID-19 confirmed sera (n = 2), from Senegal (D) were analyzed by ELISA. The proportion of individuals with antibodies against either or both the SARS-CoV-2 S and N proteins is illustrated (C).